Management of Febrile Neutropenia: A Description of Clinical and Microbiological Findings by Focusing on Risk Factors and Pitfalls.

A mortality rate in FN patients varies 2.6%–50.6%, depending on the presence of comorbidity and underlying cancer.[ 9 ] Solid tumor patients have lower rate of mortality compared with hematological malignancies, which the latter also associates higher rate of bacteremia and opportunistic infections.[ 9 ] In an epidemiological survey by the UK group in 2011, the annual incidence of FN among solid tumor patients was estimated about 2/1000 oncology admissions, while the attributed mortality was 12.5%.[ 10 ] Furthermore, it appears the mortality rate and infectious condition has a decreasing trend during recent years.

also in 47,180 other papers